ARTICLE | Clinical News
MP4CO regulatory update
November 22, 2010 8:00 AM UTC
FDA granted Orphan Drug designation for Sangart's MP4CO to treat acute painful sickling crises in patients with sickle cell disease. The pegylated carboxyhemoglobin has Orphan Drug designation in the ...